Research.Patient.info
Epithelial Ovarian Cancer research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE3
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
This study is for women with advanced ovarian cancer who've had their first treatment. It's testing if two medications, rucaparib and nivolumab, given after initial treatment, can help prevent the cancer from returning or growing. It compares these drugs to dummy treatments.
United States · Australia · Belgium - recruitingPHASE2
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
The CATALINA-2 study is investigating a new drug called TORL-1-23 for women with advanced ovarian, primary peritoneal, or fallopian tube cancer that has stopped responding to platinum-based chemotherapy. It aims to see how safe and effective this new treatment is.
United States · Australia · Austria